Back to ZBIO
CITADEL ADVISORS LLC ZBIO Position History
Zenas BioPharma, Inc. • Healthcare
Quarters held
12
Latest value
$738K
Q2 2026
Peak value
$26M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $8.3M |
| Q1 2026 | $520K |
| Q1 2026 | $1.3M |
| Q1 2026 | $669K |
| Q2 2026 | $4.2M |
| Q2 2026 | $26M |
| Q2 2026 | $784K |
| Q2 2026 | $738K |
| Q2 2026 | $4.2M |
| Q2 2026 | $26M |
| Q2 2026 | $784K |
| Q2 2026 | $738K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $738K | 29.1K | — | — |
| Q2 2026 | $784K | 30.9K | — | — |
| Q2 2026 | $26M | 21.70M | — | — |
| Q2 2026 | $4.2M | 166.7K | — | — |
| Q2 2026 | $738K | 29.1K | — | — |
| Q2 2026 | $784K | 30.9K | — | — |
| Q2 2026 | $26M | 21.70M | — | — |
| Q2 2026 | $4.2M | 166.7K | — | — |
| Q1 2026 | $669K | 34.2K | — | — |
| Q1 2026 | $1.3M | 66.9K | — | — |
| Q1 2026 | $520K | 26.6K | — | — |
| Q1 2026 | $8.3M | 8.00M | — | — |